Matt Angel

Matt Angel

Company: Factor Biosciences

Job title: Chief Executive Officer


Ensuring Safety in Gene-Edited iPSC Therapies to Accelerate Development of Next-Generation Treatments 12:30 pm

Focusing on methods for maintaining genomic stability and minimizing mosaicism after gene editing in iPSCs, promoting safety Developing new genomic stability testing methods to ensure the safety of iPSC-derived cell therapiesRead more

day: Day Two Track A AM

Regulatory Roundtables: Case Studies & Lessons Learned 6:00 pm

Join a dynamic roundtable discussion featuring experts who have successfully navigated the regulatory landscape for iPSC therapies. This session will present real-world case studies exploring the challenges and solutions encountered during various stages of development, from preclinical studies to clinical trials. Attendees will have the opportunity to ask questions and gain valuable insights into navigating…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.